This protocol addresses hepatic encephalopathy occurring in the context of liver cirrhosis complicated by hepatic myelopathy — a rare neurological complication characterised by rapidly progressing spastic paraparesis without sensory deficit or sphincter dysfunction.
Hepatic myelopathy is a rare complication of cirrhosis, most often associated with extensive portosystemic shunts. Its hallmark is a rapid motor deterioration — lower-limb spasticity and paraparesis — that does not respond to standard therapies for hepatic encephalopathy, making this a distinct and urgent clinical situation.
Given the absence of effective conventional therapies for this condition, the approach involves a specific surgical intervention that should be considered promptly in eligible patients.
Hepatic myelopathy is a rare complication of cirrhosis that is most often (>80%) accompanied by extensive portosystemic shunts.
It is characterised by rapidly progressing spastic paraparesis without sensory deficit or sphincter dysfunction and does not respond to standard therapies for HE.
In patients with hepatic myelopathy, liver transplantation should be considered as soon as possible since there is no other therapeutic option (LoE 4, strong recommendation, 94% consensus).
DOI: 10.1016/j.jhep.2022.06.001